董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jeffrey Thramann | 男 | President and Chief Executive Officer, Executive Chairman and Director | 61 | 55.17万美元 | 5.56 | 2026-03-04 |
| Nick Balletta | 男 | Director | 61 | 7.99万美元 | 未持股 | 2026-03-04 |
| Emmanuel de Boucaud | 男 | Director | 59 | 8.06万美元 | 未持股 | 2026-03-04 |
| Joshua Sroge | 男 | Director and Lead Independent Director | 57 | 6.31万美元 | 未持股 | 2026-03-04 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jeffrey Thramann | 男 | President and Chief Executive Officer, Executive Chairman and Director | 61 | 55.17万美元 | 5.56 | 2026-03-04 |
| John Mahoney | 男 | Chief Financial Officer | 60 | 31.61万美元 | 0.89 | 2026-03-04 |
董事简历
中英对照 | 中文 | 英文- Jeffrey Thramann
-
Jeffrey Thramann于2011年创立了Clip Interactive，负责公司的战略举措、资本化和治理。这包括日常参与与管理层合作以建立公司的愿景，优先考虑产品发布，与首席执行官和首席财务官合作制定公司的财务计划，并协助首席执行官招聘和雇用高级管理人员以及追求业务发展活动。它还包括领导为公司确保资本的努力，建立董事会和领导董事会会议。2002年，Thramann博士是Lanx，LLC的创始人并成为董事长。Lanx是一家创新的医疗器械公司，专注于脊柱植入物市场，并通过推出其专利的Aspen产品创建了棘间过程融合空间。Lanx于2013年被出售给国际骨科集团Biomet，Inc.。在加入Lanx的同时，2006年，Thramann博士还是Pronerve，LLC的创始人兼董事长。PRONERVE是一家梦百合服务公司，在影响大脑和脊髓的高危手术过程中提供神经功能监测。Pronerve于2012年被出售给私募股权公司Waud Capital Partners。任职Pronerve公司之前，并同时任职Lanx公司，Thramann博士曾担任U.S.RadioSurgery USR的创始人兼主席。USR是一家梦百合服务公司，为全身肿瘤提供先进的放射外科治疗。USR成为美国最大的机器人引导电子刀治疗此类肿瘤的提供商，并于2011年出售给Alliance梦百合Services（NASDAQ:AIQ）。2001-2008，Thramann是Boulder Neurosurgical Associates的创始人、高级合伙人，这是服务于科罗拉多州Boulder County的神经外科执业。Thramann博士是50多项美国和国际已发布和正在申请的专利的指定发明人。他于2001年在亚利桑那州凤凰城的巴罗神经研究所（Barrow Neurological Institute）完成了他的神经外科住院医师和复杂脊柱重建奖学金。他毕业于纽约市康奈尔大学医学院（Cornell University Medical College），并在纽约州西点军校（United States Military Academy）获得电气工程管理理学学士学位。
Jeffrey Thramann founded the Company in 2012 and oversees strategic initiatives, capitalization and governance at the Company. This includes day to day involvement in working with senior management to establish the strategic vision of the Company, prioritizing product launches, working with the CEO and CFO on the financial plans of the Company, and assisting the CEO in recruitment and hiring of senior executives and the pursuit of biness development activities. It also includes leading efforts to secure capital for the Company, building the board of directors and leading board meetings. In 2002, Dr. Thramann was the founder and became the chairman of Lanx, LLC. Lanx was an innovative medical device company foced on the spinal implant market and created the interspino process fion space with the introduction of its patented Aspen product. Lanx was sold to Biomet, Inc., an international orthopedic conglomerate, in 2013. Concurrent with Lanx, in 2006 Dr. Thramann was also the founder and chairman of ProNerve, LLC. ProNerve was a healthcare services company that provided monitoring of nerve function during high risk surgical procedures affecting the brain and spinal cord. ProNerve was sold to Waud Capital Partners, a private equity firm, in 2012. - Jeffrey Thramann于2011年创立了Clip Interactive，负责公司的战略举措、资本化和治理。这包括日常参与与管理层合作以建立公司的愿景，优先考虑产品发布，与首席执行官和首席财务官合作制定公司的财务计划，并协助首席执行官招聘和雇用高级管理人员以及追求业务发展活动。它还包括领导为公司确保资本的努力，建立董事会和领导董事会会议。2002年，Thramann博士是Lanx，LLC的创始人并成为董事长。Lanx是一家创新的医疗器械公司，专注于脊柱植入物市场，并通过推出其专利的Aspen产品创建了棘间过程融合空间。Lanx于2013年被出售给国际骨科集团Biomet，Inc.。在加入Lanx的同时，2006年，Thramann博士还是Pronerve，LLC的创始人兼董事长。PRONERVE是一家梦百合服务公司，在影响大脑和脊髓的高危手术过程中提供神经功能监测。Pronerve于2012年被出售给私募股权公司Waud Capital Partners。任职Pronerve公司之前，并同时任职Lanx公司，Thramann博士曾担任U.S.RadioSurgery USR的创始人兼主席。USR是一家梦百合服务公司，为全身肿瘤提供先进的放射外科治疗。USR成为美国最大的机器人引导电子刀治疗此类肿瘤的提供商，并于2011年出售给Alliance梦百合Services（NASDAQ:AIQ）。2001-2008，Thramann是Boulder Neurosurgical Associates的创始人、高级合伙人，这是服务于科罗拉多州Boulder County的神经外科执业。Thramann博士是50多项美国和国际已发布和正在申请的专利的指定发明人。他于2001年在亚利桑那州凤凰城的巴罗神经研究所（Barrow Neurological Institute）完成了他的神经外科住院医师和复杂脊柱重建奖学金。他毕业于纽约市康奈尔大学医学院（Cornell University Medical College），并在纽约州西点军校（United States Military Academy）获得电气工程管理理学学士学位。
- Jeffrey Thramann founded the Company in 2012 and oversees strategic initiatives, capitalization and governance at the Company. This includes day to day involvement in working with senior management to establish the strategic vision of the Company, prioritizing product launches, working with the CEO and CFO on the financial plans of the Company, and assisting the CEO in recruitment and hiring of senior executives and the pursuit of biness development activities. It also includes leading efforts to secure capital for the Company, building the board of directors and leading board meetings. In 2002, Dr. Thramann was the founder and became the chairman of Lanx, LLC. Lanx was an innovative medical device company foced on the spinal implant market and created the interspino process fion space with the introduction of its patented Aspen product. Lanx was sold to Biomet, Inc., an international orthopedic conglomerate, in 2013. Concurrent with Lanx, in 2006 Dr. Thramann was also the founder and chairman of ProNerve, LLC. ProNerve was a healthcare services company that provided monitoring of nerve function during high risk surgical procedures affecting the brain and spinal cord. ProNerve was sold to Waud Capital Partners, a private equity firm, in 2012.
- Nick Balletta
-
Nick Balletta曾担任Sea Street Technologies的总裁，该公司是一家自动化网络安全解决方案公司，将防火墙功能与人工智能驱动的威胁情报相结合。2019年6月，Balletta先生与他人共同创立了InnovoEdge，这是一个用于通用多云编排的SaaS平台，该平台于2021年8月被Megaport Ltd收购。随后，他于2021年8月至2023年9月担任Megaport全球企业发展执行副总裁。Balletta先生拥有罗格斯大学的MBA和市场营销理学学士学位。
Nick Balletta has served as President of Sea Street Technologies, an automated cybersecurity solution company that combines firewall capabilities with AI pored threat intelligence. In June 2019, Mr. Balletta co founded InnovoEdge, a SaaS platform for universal multi cloud orchestration, which was acquired by Megaport Ltd in Augt 2021. He then served as Executive Vice President of Global Corporate Development at Megaport from Augt 2021 to September 2023. Mr. Balletta holds an MBA and a Bachelor of Science in Marketing from Rutgers University. - Nick Balletta曾担任Sea Street Technologies的总裁，该公司是一家自动化网络安全解决方案公司，将防火墙功能与人工智能驱动的威胁情报相结合。2019年6月，Balletta先生与他人共同创立了InnovoEdge，这是一个用于通用多云编排的SaaS平台，该平台于2021年8月被Megaport Ltd收购。随后，他于2021年8月至2023年9月担任Megaport全球企业发展执行副总裁。Balletta先生拥有罗格斯大学的MBA和市场营销理学学士学位。
- Nick Balletta has served as President of Sea Street Technologies, an automated cybersecurity solution company that combines firewall capabilities with AI pored threat intelligence. In June 2019, Mr. Balletta co founded InnovoEdge, a SaaS platform for universal multi cloud orchestration, which was acquired by Megaport Ltd in Augt 2021. He then served as Executive Vice President of Global Corporate Development at Megaport from Augt 2021 to September 2023. Mr. Balletta holds an MBA and a Bachelor of Science in Marketing from Rutgers University.
- Emmanuel de Boucaud
-
Emmanuel L. de Boucaud是一名投资和技术主管，自2019年8月起担任结构融资公司Chisos Capital的管理合伙人。自2017年起，他还担任精品资本咨询业务IsleSail Partners的独资经营者。Boucaud先生还在多家私营公司的董事会任职。Boucaud先生拥有西方学院经济学学士学位。
Emmanuel de Boucaud is an investment and technology executive who has served as a Managing Partner at Chisos Capital, a structured finance firm, since August 2019. He has also served as the sole proprietor of IsleSail Partners, a boutique capital advisory biness, since 2017. Mr. Boucaud also serves on several boards of directors of privately held companies. Mr. Boucaud holds a bachelor's degree in Economics from Occidental College. - Emmanuel L. de Boucaud是一名投资和技术主管，自2019年8月起担任结构融资公司Chisos Capital的管理合伙人。自2017年起，他还担任精品资本咨询业务IsleSail Partners的独资经营者。Boucaud先生还在多家私营公司的董事会任职。Boucaud先生拥有西方学院经济学学士学位。
- Emmanuel de Boucaud is an investment and technology executive who has served as a Managing Partner at Chisos Capital, a structured finance firm, since August 2019. He has also served as the sole proprietor of IsleSail Partners, a boutique capital advisory biness, since 2017. Mr. Boucaud also serves on several boards of directors of privately held companies. Mr. Boucaud holds a bachelor's degree in Economics from Occidental College.
- Joshua Sroge
-
Joshua Sroge，是一名投资专业人士，自2014年1月起担任战略财务和会计服务公司Firestone CFO的负责人。自2020年5月以来，Sroge先生还一直是数字资产和加密货币投资公司BXE Capital的合伙人。Sroge先生在Banq Inc.于2023年申请破产期间担任临时首席执行官；该案随后被驳回。此前，Sroge先生于2020年1月至2021年10月期间担任Binance.US的首席财务官，并于2021年8月至2021年10月期间担任临时首席执行官。Stroge先生目前担任Hedera基金会的董事，并于2022年2月至2025年6月期间担任该基金会的首席财务官。
Joshua Sroge is an investment professional who has served as the principal of Firestone CFO, a strategic finance and accounting services firm, since January 2014. Mr. Sroge has also been a Partner at BXE Capital, a digital asset and cryptocurrency investment firm, since May 2020. Mr. Sroge served as Interim Chief Executive Officer of Banq Inc. during its bankruptcy filing in 2023; the case was subsequently dismissed. Previoly, Mr. Sroge served as the Chief Financial Officer of Binance. from January 2020 to October 2021, where he also served as Interim Chief Executive Officer from Augt 2021 to October 2021. Mr. Sroge currently serves as a Director of the Hedera Foundation, where he also served as Chief Financial Officer from February 2022 to June 2025. - Joshua Sroge，是一名投资专业人士，自2014年1月起担任战略财务和会计服务公司Firestone CFO的负责人。自2020年5月以来，Sroge先生还一直是数字资产和加密货币投资公司BXE Capital的合伙人。Sroge先生在Banq Inc.于2023年申请破产期间担任临时首席执行官；该案随后被驳回。此前，Sroge先生于2020年1月至2021年10月期间担任Binance.US的首席财务官，并于2021年8月至2021年10月期间担任临时首席执行官。Stroge先生目前担任Hedera基金会的董事，并于2022年2月至2025年6月期间担任该基金会的首席财务官。
- Joshua Sroge is an investment professional who has served as the principal of Firestone CFO, a strategic finance and accounting services firm, since January 2014. Mr. Sroge has also been a Partner at BXE Capital, a digital asset and cryptocurrency investment firm, since May 2020. Mr. Sroge served as Interim Chief Executive Officer of Banq Inc. during its bankruptcy filing in 2023; the case was subsequently dismissed. Previoly, Mr. Sroge served as the Chief Financial Officer of Binance. from January 2020 to October 2021, where he also served as Interim Chief Executive Officer from Augt 2021 to October 2021. Mr. Sroge currently serves as a Director of the Hedera Foundation, where he also served as Chief Financial Officer from February 2022 to June 2025.
高管简历
中英对照 | 中文 | 英文- Jeffrey Thramann
Jeffrey Thramann于2011年创立了Clip Interactive，负责公司的战略举措、资本化和治理。这包括日常参与与管理层合作以建立公司的愿景，优先考虑产品发布，与首席执行官和首席财务官合作制定公司的财务计划，并协助首席执行官招聘和雇用高级管理人员以及追求业务发展活动。它还包括领导为公司确保资本的努力，建立董事会和领导董事会会议。2002年，Thramann博士是Lanx，LLC的创始人并成为董事长。Lanx是一家创新的医疗器械公司，专注于脊柱植入物市场，并通过推出其专利的Aspen产品创建了棘间过程融合空间。Lanx于2013年被出售给国际骨科集团Biomet，Inc.。在加入Lanx的同时，2006年，Thramann博士还是Pronerve，LLC的创始人兼董事长。PRONERVE是一家梦百合服务公司，在影响大脑和脊髓的高危手术过程中提供神经功能监测。Pronerve于2012年被出售给私募股权公司Waud Capital Partners。任职Pronerve公司之前，并同时任职Lanx公司，Thramann博士曾担任U.S.RadioSurgery USR的创始人兼主席。USR是一家梦百合服务公司，为全身肿瘤提供先进的放射外科治疗。USR成为美国最大的机器人引导电子刀治疗此类肿瘤的提供商，并于2011年出售给Alliance梦百合Services（NASDAQ:AIQ）。2001-2008，Thramann是Boulder Neurosurgical Associates的创始人、高级合伙人，这是服务于科罗拉多州Boulder County的神经外科执业。Thramann博士是50多项美国和国际已发布和正在申请的专利的指定发明人。他于2001年在亚利桑那州凤凰城的巴罗神经研究所（Barrow Neurological Institute）完成了他的神经外科住院医师和复杂脊柱重建奖学金。他毕业于纽约市康奈尔大学医学院（Cornell University Medical College），并在纽约州西点军校（United States Military Academy）获得电气工程管理理学学士学位。
Jeffrey Thramann founded the Company in 2012 and oversees strategic initiatives, capitalization and governance at the Company. This includes day to day involvement in working with senior management to establish the strategic vision of the Company, prioritizing product launches, working with the CEO and CFO on the financial plans of the Company, and assisting the CEO in recruitment and hiring of senior executives and the pursuit of biness development activities. It also includes leading efforts to secure capital for the Company, building the board of directors and leading board meetings. In 2002, Dr. Thramann was the founder and became the chairman of Lanx, LLC. Lanx was an innovative medical device company foced on the spinal implant market and created the interspino process fion space with the introduction of its patented Aspen product. Lanx was sold to Biomet, Inc., an international orthopedic conglomerate, in 2013. Concurrent with Lanx, in 2006 Dr. Thramann was also the founder and chairman of ProNerve, LLC. ProNerve was a healthcare services company that provided monitoring of nerve function during high risk surgical procedures affecting the brain and spinal cord. ProNerve was sold to Waud Capital Partners, a private equity firm, in 2012.- Jeffrey Thramann于2011年创立了Clip Interactive，负责公司的战略举措、资本化和治理。这包括日常参与与管理层合作以建立公司的愿景，优先考虑产品发布，与首席执行官和首席财务官合作制定公司的财务计划，并协助首席执行官招聘和雇用高级管理人员以及追求业务发展活动。它还包括领导为公司确保资本的努力，建立董事会和领导董事会会议。2002年，Thramann博士是Lanx，LLC的创始人并成为董事长。Lanx是一家创新的医疗器械公司，专注于脊柱植入物市场，并通过推出其专利的Aspen产品创建了棘间过程融合空间。Lanx于2013年被出售给国际骨科集团Biomet，Inc.。在加入Lanx的同时，2006年，Thramann博士还是Pronerve，LLC的创始人兼董事长。PRONERVE是一家梦百合服务公司，在影响大脑和脊髓的高危手术过程中提供神经功能监测。Pronerve于2012年被出售给私募股权公司Waud Capital Partners。任职Pronerve公司之前，并同时任职Lanx公司，Thramann博士曾担任U.S.RadioSurgery USR的创始人兼主席。USR是一家梦百合服务公司，为全身肿瘤提供先进的放射外科治疗。USR成为美国最大的机器人引导电子刀治疗此类肿瘤的提供商，并于2011年出售给Alliance梦百合Services（NASDAQ:AIQ）。2001-2008，Thramann是Boulder Neurosurgical Associates的创始人、高级合伙人，这是服务于科罗拉多州Boulder County的神经外科执业。Thramann博士是50多项美国和国际已发布和正在申请的专利的指定发明人。他于2001年在亚利桑那州凤凰城的巴罗神经研究所（Barrow Neurological Institute）完成了他的神经外科住院医师和复杂脊柱重建奖学金。他毕业于纽约市康奈尔大学医学院（Cornell University Medical College），并在纽约州西点军校（United States Military Academy）获得电气工程管理理学学士学位。
- Jeffrey Thramann founded the Company in 2012 and oversees strategic initiatives, capitalization and governance at the Company. This includes day to day involvement in working with senior management to establish the strategic vision of the Company, prioritizing product launches, working with the CEO and CFO on the financial plans of the Company, and assisting the CEO in recruitment and hiring of senior executives and the pursuit of biness development activities. It also includes leading efforts to secure capital for the Company, building the board of directors and leading board meetings. In 2002, Dr. Thramann was the founder and became the chairman of Lanx, LLC. Lanx was an innovative medical device company foced on the spinal implant market and created the interspino process fion space with the introduction of its patented Aspen product. Lanx was sold to Biomet, Inc., an international orthopedic conglomerate, in 2013. Concurrent with Lanx, in 2006 Dr. Thramann was also the founder and chairman of ProNerve, LLC. ProNerve was a healthcare services company that provided monitoring of nerve function during high risk surgical procedures affecting the brain and spinal cord. ProNerve was sold to Waud Capital Partners, a private equity firm, in 2012.
- John Mahoney
John E. Mahoney，2023年11月加入公司担任首席财务官。他在服务行业带来了超过二十年的财务和运营经验，既有上市公司，也有私营公司。2019年至2023年，在Quality Biomedical，Inc.担任首席财务官，该公司是一家私募股权支持的家用医疗设备行业领先服务提供商。从2014年到2019年，Mahoney先生在CFO Leadership Services，LLC（一家零碎CFO服务公司）担任负责人兼首席财务官。2005年至2014年，Mahoney先生在TASQ Technology，Inc.担任副总裁兼首席财务官，TASQ Technology，Inc.是第一数据公司的全资子公司，后者与全球领先的信用卡处理服务公司Fiserv.合并。Mahoney先生是一名注册会计师。他在长岛大学获得公共会计学士学位。
John Mahoney joined the Company as Chief Financial Officer in November 2023. He has over tnty years of finance and operational experience in the services industry with both publicly traded and privately held companies. From 2019 to 2023, he served as Chief Financial Officer at Quality Biomedical, Inc., a private equity backed and leading service provider in the Home Medical Equipment industry. From 2014 to 2019, Mr. Mahoney served as Principal and Chief Financial Officer at CFO Leadership Services, LLC, a fractional CFO service company. From 2005 to 2014, Mr. Mahoney served Vice President and Chief Financial Officer at TASQ Technology, Inc., a wholly owned subsidiary of First Data Corporation, who merged with Fiserv. a leading global credit card processing services company. Mr. Mahoney is a certified public accountant. He earned his BS in Public Accountancy from Long Island University.- John E. Mahoney，2023年11月加入公司担任首席财务官。他在服务行业带来了超过二十年的财务和运营经验，既有上市公司，也有私营公司。2019年至2023年，在Quality Biomedical，Inc.担任首席财务官，该公司是一家私募股权支持的家用医疗设备行业领先服务提供商。从2014年到2019年，Mahoney先生在CFO Leadership Services，LLC（一家零碎CFO服务公司）担任负责人兼首席财务官。2005年至2014年，Mahoney先生在TASQ Technology，Inc.担任副总裁兼首席财务官，TASQ Technology，Inc.是第一数据公司的全资子公司，后者与全球领先的信用卡处理服务公司Fiserv.合并。Mahoney先生是一名注册会计师。他在长岛大学获得公共会计学士学位。
- John Mahoney joined the Company as Chief Financial Officer in November 2023. He has over tnty years of finance and operational experience in the services industry with both publicly traded and privately held companies. From 2019 to 2023, he served as Chief Financial Officer at Quality Biomedical, Inc., a private equity backed and leading service provider in the Home Medical Equipment industry. From 2014 to 2019, Mr. Mahoney served as Principal and Chief Financial Officer at CFO Leadership Services, LLC, a fractional CFO service company. From 2005 to 2014, Mr. Mahoney served Vice President and Chief Financial Officer at TASQ Technology, Inc., a wholly owned subsidiary of First Data Corporation, who merged with Fiserv. a leading global credit card processing services company. Mr. Mahoney is a certified public accountant. He earned his BS in Public Accountancy from Long Island University.